Is Exicure Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Exicure Inc (XCUR) is currently classified as DOUBTFUL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Exicure Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Exicure Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Exicure Inc?

Muslim investors may consider investing in Exicure Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Exicure Inc classified as DOUBTFUL?

Musaffa determines the Shariah status of Exicure Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Exicure Inc updated?

The Shariah compliance status of Exicure Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Exicure Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Exicure Inc?

You can check the latest Shariah compliance status of Exicure Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

XCUR Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: April 01, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Exicure Inc (XCUR)

Based on 6 analysts giving stock ratings to Exicure Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Exicure Inc. Stock Analysis XCUR

United States Health Care Nano Cap Report: 2025 Annual

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 8 full-time employees. The company went IPO on 2018-05-09. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The firm is also exploring strategic alternatives to maximize stockholder value.

Key Statistics of Exicure Inc (XCUR)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.78$3.02

Today's Open

$3.00

Volume

33.11K

P/E Ratio (TTM)

52 Week Range

$2.78$11.00

Market Cap

24.14M

Avg. Volume

16.51K

Dividend Yield

Financial Metrics & Statements of Exicure Inc (XCUR)

Community-Curated Collections with Exicure Inc (XCUR) ( With XCUR )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

A

By Mustafa SARICA

15 Followers

+186 more

FAQ's for Exicure Inc (XCUR)

According to Musaffa’s Shariah screening methodology, Exicure Inc (XCUR) is currently classified as DOUBTFUL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.